OptimizeRx Corp reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Waltham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
OptimizeRx Corp has filed 1,032 SEC EDGAR filings since 12 Nov 2008

SEC filing history

Showing 76-100 of 1,000 matching filings.

Per page
25
Current page
4
SCHEDULE 13G/A File 005-85653

SCHEDULE 13G/A filing

Filing date
30 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-38543

FORM ARS

Filing date
30 Apr 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38543

PROXY STATEMENT

Filing date
30 Apr 2025
Reporting date
11 Jun 2025
Next action
Verify source filing
SCHEDULE 13D/A File 005-85653

SCHEDULE 13D/A filing

Filing date
21 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38543

CURRENT REPORT

Filing date
18 Apr 2025
Reporting date
18 Apr 2025
Next action
Verify source filing
EFFECT File 333-286224

EFFECT filing

Filing date
07 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
03 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-286224

UPLOAD filing

Filing date
02 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-286224

REGISTRATION STATEMENT

Filing date
28 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-38543

ANNUAL REPORT

Filing date
20 Mar 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
4

FORM 4

Filing date
19 Mar 2025
Reporting date
14 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38543

CURRENT REPORT

Filing date
12 Mar 2025
Reporting date
12 Mar 2025
Next action
Verify source filing
DEFA14A File 001-38543

SOLICITING MATERIAL UNDER 240.14A-12

Filing date
11 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DFAN14A File 001-38543

DFAN14A

Filing date
11 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-85653

SCHEDULE 13D/A filing

Filing date
10 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38543

CURRENT REPORT

Filing date
10 Mar 2025
Reporting date
10 Mar 2025
Next action
Verify source filing
4

FORM 4

Filing date
04 Mar 2025
Reporting date
01 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Mar 2025
Reporting date
01 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Feb 2025
Reporting date
14 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Feb 2025
Reporting date
15 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Feb 2025
Reporting date
15 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Feb 2025
Reporting date
15 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Feb 2025
Reporting date
15 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Feb 2025
Reporting date
11 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-85653

SCHEDULE 13G/A filing

Filing date
13 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .